The New England journal of medicine
-
Randomized Controlled Trial Multicenter Study
Nasal High-Flow Therapy for Newborn Infants in Special Care Nurseries.
Nasal high-flow therapy is an alternative to nasal continuous positive airway pressure (CPAP) as a means of respiratory support for newborn infants. The efficacy of high-flow therapy in nontertiary special care nurseries is unknown. ⋯ Nasal high-flow therapy was not shown to be noninferior to CPAP and resulted in a significantly higher incidence of treatment failure than CPAP when used in nontertiary special care nurseries as early respiratory support for newborn infants with respiratory distress. (Funded by the Australian National Health and Medical Research Council and Monash University; HUNTER Australian and New Zealand Clinical Trials Registry number, ACTRN12614001203640.).
-
Editorial Comment
Early Paralytic Agents for ARDS? Yes, No, and Sometimes.